SEC Comment Letter 0000000000-24-012598 to Incannex Healthcare Inc. (IXHL)
Incannex Healthcare Inc.
Date: Nov. 13, 2024 · CIK: 0001873875 · Accession: 0000000000-24-012598
AI Filing Summary & Sentiment
File numbers found in text: 333-283028
Letter
November 13, 2024 Joel Latham Chief Executive Officer Incannex Healthcare Inc. Suite 105, 8 Century Circuit Norwest NSW 2153 Australia Re:Incannex Healthcare Inc. Registration Statement on Form S-3 Filed November 6, 2024 File No. 333-283028 Dear Joel Latham: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Doris Stacey Gama at 202-551-3188 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Jason Miller, Esq.
Show Raw Text
November 13, 2024
Joel Latham
Chief Executive Officer
Incannex Healthcare Inc.
Suite 105, 8 Century Circuit Norwest
NSW 2153 Australia
Re:Incannex Healthcare Inc.
Registration Statement on Form S-3
Filed November 6, 2024
File No. 333-283028
Dear Joel Latham:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Doris Stacey Gama at 202-551-3188 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Jason Miller, Esq.